Silence Therapeutics PLC (OTCPK:SLNCF) Stock News, Headlines & Updates
Silence Therapeutics PLC Stock News from GuruFocus
- 1
Jun 27, 2024
Silence Therapeutics Announces Positive Results from Ongoing SANRECO Phase 1 Study of Divesiran in Polycythemia Vera Patients
Business Wire • 7:00am
Jun 24, 2024
Silence Therapeutics Achieves $2 Million Research Milestone Payment from Hansoh Pharma Collaboration
Business Wire • 8:00am
Jun 20, 2024
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
Business Wire • 7:00am
May 30, 2024
Silence Therapeutics to Present at Jefferies Global Healthcare Conference
Business Wire • 8:00am
May 16, 2024
Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
Business Wire • 8:00am
Apr 30, 2024
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Business Wire • 8:00am
Apr 29, 2024
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
Business Wire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news